LncRNA BC087858 has been shown to be upregulated in NSCLC cell lines with acquired resistance to erlotinib compared to sensitive or intrinsically resistant cell lines and similarly to be upregulated in patients who developed resistance to erlotinib compared to levels prior to EGFR TKI treatment. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.